ImageneBio (IMA) Research & Development (2020 - 2024)
Historic Research & Development for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to $2.5 million.
- ImageneBio's Research & Development fell 8231.05% to $2.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $25.9 million, marking a year-over-year decrease of 5660.33%. This contributed to the annual value of $30.9 million for FY2024, which is 4824.15% down from last year.
- Per ImageneBio's latest filing, its Research & Development stood at $2.5 million for Q4 2024, which was down 8231.05% from $3.9 million recorded in Q3 2024.
- ImageneBio's Research & Development's 5-year high stood at $23.4 million during Q4 2020, with a 5-year trough of $2.5 million in Q4 2024.
- For the 5-year period, ImageneBio's Research & Development averaged around $12.1 million, with its median value being $12.9 million (2021).
- Per our database at Business Quant, ImageneBio's Research & Development surged by 8530.06% in 2021 and then crashed by 8231.05% in 2024.
- Quarter analysis of 5 years shows ImageneBio's Research & Development stood at $23.4 million in 2020, then plummeted by 47.28% to $12.3 million in 2021, then increased by 26.75% to $15.6 million in 2022, then fell by 8.73% to $14.3 million in 2023, then tumbled by 82.31% to $2.5 million in 2024.
- Its last three reported values are $2.5 million in Q4 2024, $3.9 million for Q3 2024, and $9.8 million during Q2 2024.